CoChat

Cisplatin-induced chemoresistance in colon cancer cells involves FXR-dependent and FXR-independent up-regulation of ABC proteins.

Open access
Herraez, Elisa, Gonzalez-Sanchez, Ester, Vaquero, Javier, Romero, Marta R., Serrano, Maria A., Marin, Jose J. G., Briz, Oscar · 2012 · Molecular Pharmaceutics

The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.

Abstract

Export pumps often limit the usefulness of anticancer drugs. Here we investigated the effect of cisplatin on the expression of ABC proteins in human colon cancer cells. Short-term incubation of Caco-2 and LS174T cells with cisplatin resulted in up-regulation of several ABC pumps, in particular MRP2 and BCRP. In partially cisplatin-resistant cells (LS174T/R) obtained by long-term exposure to cisplatin, MRP2 and BCRP up-regulation was more marked. This was further enhanced when these cells were cultured under maintained stimulation with cisplatin. The MRP2 promoter (MRP2pr) was cloned, and partially deleted constructs linked to reporter genes were generated. Transfection of LS174T and LS174T/R cells with these constructs revealed the ability of cisplatin to activate MRP2pr. The intensity of this response was dependent on the conserved MRP2pr region. Basal MRP2pr activity was higher in LS174T/R cells, in which the expression of the transcription factors c/EBPβ, HNF1α, HNF3β, and HNF4α, but not PXR, p53, c-Myc, AP1, YB-1, NRF2, and RARα was enhanced. Up-regulation was particularly high for FXR (200-fold) and SHP (50-fold). In LS174T/R cells, GW4064 induced the expression of FGF19, SHP, OSTα/β, but not MRP2 and BCRP, although the sensitivity of these cells to cisplatin was further reduced. In LS174T cells, GW4064-induced chemoresistance was seen only after being transfected with FXR+RXR, when BCRP, but not MRP2, was up-regulated. Protection of LS174T cells against cisplatin was mimicked by transfection with BCRP. In conclusion, in colon cancer cells, cisplatin treatment enhances chemoresistance through FXR-dependent and FXR-independent mechanisms involving the expression of BCRP and MRP2, respectively.

Overview

Integrity signals

Registry

Crossref · 10.1021/mp300178a

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

The text we found for this paper looks like another document, so its claims and self-check weren’t run. The registry and citation checks still apply.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The text we found for this paper looks like another document, so the self-check wasn’t run.

Citations

Cites

Show all 42 references

Research works printed but not linked: 8

  1. Boulikas T., 2003, Oncol. Rep., 10, 1663
  2. Samimi G., 2003, Clin. Cancer Res., 9, 5853
  3. Komatsu M., 2000, Cancer Res., 60, 1312
  4. Hinoshita E., 2000, Clin. Cancer Res., 6, 2401
  5. Kool M., 1997, Cancer Res., 57, 3537
  6. Koike K., 1997, Cancer Res., 57, 5475
  7. Wang Q., 1998, Cancer Res., 58, 5762
  8. To K. K., 2011, Mol. Carcinog., 51, 449

Cited by

See all 69

Metadata

Authors
Herraez, E., Gonzalez-Sanchez, E., Vaquero, J., Romero, M. R., Serrano, M. A., Marin, J. J. G., & Briz, O.
Affiliations
  • Laboratory of Experimental Hepatology and Drug Targeting (HEVEFARM), Biomedical Research Institute of Salamanca (IBSAL), University of Salamanca, Spain
  • Universidad de Salamanca (ES)
Venue
Molecular Pharmaceutics
Published
2012-08-01
Volume
9
Issue
9
Pages
2565-2576
ISSN
  • 1543-8384 (ISSN-L)
  • 1543-8392
OpenAlex
W2092149794
Cited by
67
References
42
Citations by year
2026: 3 · 2025: 4 · 2024: 1 · 2023: 6 · 2022: 2 · 2021: 6 · 2020: 3 · 2019: 3 · 2018: 4 · 2017: 5 · 2016: 7 · 2015: 5 · 2014: 8 · 2013: 8 · 2012: 2
FWCI
3.64
Type
journal article
Language
en
Open access
Licence
cc-by-nc-nd
Locations
  • Molecular Pharmaceutics (publishedVersion)
  • PubMed (publishedVersion)
  • Gredos (University of Salamanca) (acceptedVersion, cc-by-nc-nd)
  • Hispana (acceptedVersion, cc-by-nc-nd)
Funders
Instituto de Salud Carlos III
Topics
  • Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
  • Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
Keywords
cisplatin, chemoresistance, colon cancer, ABC transporters, MRP2, ABCG2, farnesoid X receptor, SHP, transcriptional activation, HNF4α, HNF1A, FGF19, GW4064, Caco-2 cells, LS174T cells
MeSH terms
ATP Binding Cassette Transporter, Subfamily G, Member 2, Receptor, Farnesoid X-Activated, Cisplatin, Colonic Neoplasms, DNA-Binding Proteins, Humans, Microfilament Proteins, Neoplasm Proteins, Promoter Regions, Genetic, Transcription Factors, Transfection, Transcriptional Activation, Up-Regulation, Gene Expression, Genes, Reporter, Receptors, Cytoplasmic and Nuclear, ATP-Binding Cassette Transporters, Caco-2 Cells, Drug Resistance, Neoplasm, Cell Line, Tumor, Hep G2 Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.